Corticotropin-releasing factor-induced immunosuppression in human and invertebrate immunocytes

E M Smith1, T K Hughes, P Cadet

  • 1Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston 77550.

Insights

Corticotropin-releasing factor (CRF) influences neuroimmune processes, mimicking alpha-melanocyte stimulating hormone (MSH). Specific CRF receptors on immunocytes mediate these effects and antagonism of tumor necrosis factor.

Area of Science:

  • Neuroimmunology
  • Comparative immunology
  • Endocrinology

Background:

  • Corticotropin-releasing factor (CRF) is implicated in neuroimmune and autoimmunoregulatory processes across species.
  • CRF's signaling actions resemble those of alpha-melanocyte stimulating hormone (MSH) but with a longer duration.

Purpose of the Study:

  • To investigate the role of CRF in immune cell function.
  • To determine the specificity of CRF and MSH interactions with immunocytes.
  • To identify potential receptors for CRF on immunocytes.

Main Methods:

  • Utilized alpha-helical CRF as a specific CRF inhibitor.
  • Examined the effects of CRF and MSH on cellular immunosuppression.
  • Assessed the impact of CRF and MSH on tumor necrosis factor (TNF) stimulation of immunocytes.
  • Investigated immunocyte receptor binding for CRF.

Main Results:

  • Alpha-helical CRF inhibited CRF-induced immunosuppression but not MSH-induced immunosuppression.
  • Both human and Mytilus immunocytes possess specific CRF receptors.
  • CRF and MSH antagonized TNF-stimulated immunocyte activity.
  • Alpha-helical CRF selectively blocked CRF's antagonism of TNF, confirming distinct receptor pathways.

Conclusions:

  • CRF acts as a significant signaling molecule in neuroimmune regulation, distinct from MSH.
  • Evidence supports the presence of specific CRF receptors on both human and invertebrate immunocytes.
  • CRF and MSH modulate immune cell responses, including those involving TNF, via separate receptor mechanisms.

Related Concept Videos